Annual D&A
$259.00 K
+$145.00 K+127.19%
December 31, 2023
Summary
- As of February 12, 2025, GRTX annual depreciation & amortization is $259.00 thousand, with the most recent change of +$145.00 thousand (+127.19%) on December 31, 2023.
- During the last 3 years, GRTX annual D&A has fallen by -$109.00 thousand (-29.62%).
- GRTX annual D&A is now -66.71% below its all-time high of $778.00 thousand, reached on December 31, 2021.
Performance
GRTX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$5000.00
-$1000.00-16.67%
September 1, 2024
Summary
- As of February 12, 2025, GRTX quarterly depreciation & amortization is $5000.00, with the most recent change of -$1000.00 (-16.67%) on September 1, 2024.
- Over the past year, GRTX quarterly D&A has dropped by -$210.00 thousand (-97.67%).
- GRTX quarterly D&A is now -98.92% below its all-time high of $464.00 thousand, reached on December 31, 2021.
Performance
GRTX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$235.00 K
-$7000.00-2.89%
September 1, 2024
Summary
- As of February 12, 2025, GRTX TTM depreciation & amortization is $235.00 thousand, with the most recent change of -$7000.00 (-2.89%) on September 1, 2024.
- Over the past year, GRTX TTM D&A has dropped by -$24.00 thousand (-9.27%).
- GRTX TTM D&A is now -69.79% below its all-time high of $778.00 thousand, reached on December 31, 2021.
Performance
GRTX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
GRTX Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +127.2% | -97.7% | -9.3% |
3 y3 years | -29.6% | -97.7% | -9.3% |
5 y5 years | +103.9% | -97.7% | -9.3% |
GRTX Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -66.7% | +127.2% | -98.9% | at low | -69.8% | +235.7% |
5 y | 5-year | -66.7% | +127.2% | -98.9% | at low | -69.8% | +235.7% |
alltime | all time | -66.7% | +208.3% | -98.9% | at low | -69.8% | +410.9% |
Galera Therapeutics Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $5000.00(-16.7%) | $235.00 K(-2.9%) |
Jun 2024 | - | $6000.00(-33.3%) | $242.00 K(-2.4%) |
Mar 2024 | - | $9000.00(-95.8%) | $248.00 K(-4.2%) |
Dec 2023 | $259.00 K(+127.2%) | $215.00 K(+1691.7%) | $259.00 K(+270.0%) |
Sep 2023 | - | $12.00 K(0.0%) | $70.00 K(-17.6%) |
Jun 2023 | - | $12.00 K(-40.0%) | $85.00 K(-17.5%) |
Mar 2023 | - | $20.00 K(-23.1%) | $103.00 K(-9.6%) |
Dec 2022 | $114.00 K(-85.3%) | $26.00 K(-3.7%) | $114.00 K(-79.3%) |
Sep 2022 | - | $27.00 K(-10.0%) | $552.00 K(-12.5%) |
Jun 2022 | - | $30.00 K(-3.2%) | $631.00 K(-10.2%) |
Mar 2022 | - | $31.00 K(-93.3%) | $703.00 K(-9.6%) |
Dec 2021 | $778.00 K | $464.00 K(+337.7%) | $778.00 K(+89.8%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2021 | - | $106.00 K(+3.9%) | $410.00 K(+2.2%) |
Jun 2021 | - | $102.00 K(-3.8%) | $401.00 K(+1.8%) |
Mar 2021 | - | $106.00 K(+10.4%) | $394.00 K(+7.1%) |
Dec 2020 | $368.00 K(+37.8%) | $96.00 K(-1.0%) | $368.00 K(+4.8%) |
Sep 2020 | - | $97.00 K(+2.1%) | $351.00 K(+6.7%) |
Jun 2020 | - | $95.00 K(+18.8%) | $329.00 K(+9.3%) |
Mar 2020 | - | $80.00 K(+1.3%) | $301.00 K(+12.7%) |
Dec 2019 | $267.00 K(+110.2%) | $79.00 K(+5.3%) | $267.00 K(+42.0%) |
Sep 2019 | - | $75.00 K(+11.9%) | $188.00 K(+66.4%) |
Jun 2019 | - | $67.00 K(+45.7%) | $113.00 K(+145.7%) |
Mar 2019 | - | $46.00 K | $46.00 K |
Dec 2018 | $127.00 K(+51.2%) | - | - |
Dec 2017 | $84.00 K | - | - |
FAQ
- What is Galera Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Galera Therapeutics?
- What is Galera Therapeutics annual D&A year-on-year change?
- What is Galera Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Galera Therapeutics?
- What is Galera Therapeutics quarterly D&A year-on-year change?
- What is Galera Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Galera Therapeutics?
- What is Galera Therapeutics TTM D&A year-on-year change?
What is Galera Therapeutics annual depreciation & amortization?
The current annual D&A of GRTX is $259.00 K
What is the all time high annual D&A for Galera Therapeutics?
Galera Therapeutics all-time high annual depreciation & amortization is $778.00 K
What is Galera Therapeutics annual D&A year-on-year change?
Over the past year, GRTX annual depreciation & amortization has changed by +$145.00 K (+127.19%)
What is Galera Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of GRTX is $5000.00
What is the all time high quarterly D&A for Galera Therapeutics?
Galera Therapeutics all-time high quarterly depreciation & amortization is $464.00 K
What is Galera Therapeutics quarterly D&A year-on-year change?
Over the past year, GRTX quarterly depreciation & amortization has changed by -$210.00 K (-97.67%)
What is Galera Therapeutics TTM depreciation & amortization?
The current TTM D&A of GRTX is $235.00 K
What is the all time high TTM D&A for Galera Therapeutics?
Galera Therapeutics all-time high TTM depreciation & amortization is $778.00 K
What is Galera Therapeutics TTM D&A year-on-year change?
Over the past year, GRTX TTM depreciation & amortization has changed by -$24.00 K (-9.27%)